Biomerica, Inc.
(NASDAQ: BMRA)

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.

2.330

+0.027 (+1.17%)
Range 2.306 - 2.380   (3.21%)
Open 2.310
Previous Close 2.303
Bid Price 1.670
Bid Volume 9
Ask Price 1.690
Ask Volume 10
Volume 5,189
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 01:43.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis